Substituted cyclopropyl compounds useful as GPR119 agonists
US9018224B2 · kind B2 · utility
1Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2012 |
| Grant date | Apr 28, 2015 |
| Priority date | — |
| Expiry date | Nov 9, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted cyclopropyl compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.